ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| 54.5 | |
| 54.5 | |
| - | |
| 55 | |
| 54.5 | |
| 44.2-64 | |
| 1 176 M | |
| 21 018 K | |
| 555 M | |
| 0.71 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ANI Pharmaceuticals ANIP is set to report second-quarter 2023 results on Aug 9 before market open, wherein investors are likely to focus on the sales performance of the company’s core business segme...
ANI Pharmaceuticals, Inc. BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release it...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
